Creative Planning’s Eledon Pharmaceuticals ELDN Stock Holding History

Creative Planning’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92.4K	Buy	+23,459	New	+$85.3K	﹤0.01%	4051
2017 Q3	–	Sell	-8	Closed	-$1K	–	2395
2017 Q2	$1K	Buy	+8	New	+$815	﹤0.01%	4427
2016 Q3	–	Sell	-20	Closed	-$18K	–	4608
2016 Q2	$18K	Hold	20	–	–	﹤0.01%	2865
2016 Q1	$19K	Hold	20	–	–	﹤0.01%	2783
2015 Q4	$29K	Hold	20	–	–	﹤0.01%	2567
2015 Q3	$34K	Buy	+20	New	+$41.2K	﹤0.01%	2325
2015 Q2	–	Sell	-20	Closed	-$37K	–	1631
2015 Q1	$37K	Hold	20	–	–	﹤0.01%	2230
2014 Q4	$49K	Hold	20	–	–	﹤0.01%	2015
2014 Q3	$50K	Buy	+20	New	+$56.8K	﹤0.01%	1922

Other funds holding ELDN

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Creative Planning's ELDN Position: Q2 2026 in Review

Creative Planning opened a new position in Eledon Pharmaceuticals (ELDN) in Q2 2026: 23,459 shares worth $92.4K. The stake represents ﹤0.01% of the portfolio and ranks #4051 among its holdings. This is a return to the name: Creative Planning previously reported a position in ELDN as recently as Q2 2017.

Creative Planning first reported a position in ELDN in Q3 2014 and has held it in 9 quarters since. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

Creative Planning held 23,459 shares of Eledon Pharmaceuticals worth $92.4K as of Q2 2026.
Eledon Pharmaceuticals was a new Creative Planning position in Q2 2026.
Eledon Pharmaceuticals made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4051 holding.
Creative Planning first reported a position in Eledon Pharmaceuticals in Q3 2014 and has held it in 9 quarters since.
161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.